Measurement Of Fecal Zonulin And Calprotectin To Predict 6-Months Relapse Of Inflammatory Bowel Disease In Clinical Remission
Abstract Rationale: Increased gut permeability and inflammation occurs during active inflammatory bowel disease (IBD), however, a proper understanding in clinical remission remains to be elucidated. Objective: Measured fecal zonulin and calprotectin of patients with ulcerative colitis (UC) and Crohn’s disease (CD) in clinical remission and predicting relapse. Methods: Prospective longitudinal cohort study of 40 IBD patients (20 […]
Promoting equity in inflammatory bowel disease: a global approach to care
Abstract Since the turn of the century, shifts in epidemiology indicate the emergence of inflammatory bowel disease (IBD) as a truly global disease with a global health-care burden. The rapid increase in the incidence of IBD in western countries (North America and western Europe) has stabilised, but the compound prevalence in these regions is predicted […]